CIK: 1260573 - Address: C/O Graphite Bio, Inc., 201 Haskins Way, Suite 210, South San Francisco, CA 94080
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret118-112816187
S%wins88503825132540

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/18/20 16:29
12/17/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticKarsen Perry AMADS.d-4,75453.550-89-955D
5/15/15 16:29
5/13/13
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-5,425115.0033-47-4266D77527-11-37111-413-3-13
2/13/15 17:07
2/11/15
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-3,351120.1233-28-2774D134443173-7-2-2074-112-12
1/2/15 16:01
12/30/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-2,185113.3733-19-2559D1853224205-3-5-1-115156
11/14/14 16:13
11/12/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-4,227107.2333-39-4255D1894446201342-103711113
8/5/14 16:14
8/4/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-3,42387.5533-39-3962D156191818211-1-1010233551
5/5/14 18:16
5/1/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-1,750146.7833-12-3027D10224-3-32820-1-15174448
3/5/14 16:20
3/3/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS-383159.0533-2-828D12153160-4110-4-3-10-51747
8/2/13 17:46
8/2/13
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsKarsen Perry ANJOsee remaS.d-13,626146.5033-93-8714D151114502531111040-4-53317

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact